e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diagnosis and management of pleural and mediastinal diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk of occult pleural infection in patients with malignant effusions
A. Bibby, S. Dawson, A. Stanton (Swindon, United Kingdom)
Source:
Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Session:
Diagnosis and management of pleural and mediastinal diseases
Session type:
Thematic Poster Session
Number:
2930
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bibby, S. Dawson, A. Stanton (Swindon, United Kingdom). Risk of occult pleural infection in patients with malignant effusions. Eur Respir J 2013; 42: Suppl. 57, 2930
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Survival of non small cell lung carcinoma patients with malignant pleural effusions
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Differences according to age and sex among patients with malignant pleural effusion as a presentation form of cancer
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Solitary fibrous tumour of the pleural: Two malignant cases
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Comparison analysis of malignant and tuberculous pleural fluid using proteomic method
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Differentiating incidental lung nodules due to lung cancer from those due to coccidioidomycosis
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept